Medical Devices Startups
5,295 companies tagged Medical Devices, with their investors and founders.
Insightec develops Exablate Neuro, an MRI-guided focused ultrasound platform that treats Essential Tremor and tremor-dominant Parkinson's Disease through an incision-free outpatient procedure. The technology is used by neurosurgeons and clinical teams to perform precision, real-time monitored brain treatments.
7 investors
Invitae provides genetic testing services to patients and clinicians across the United States, offering broad test offerings and genetic counseling to inform health decisions at every stage of life. Now part of Labcorp, the company leverages a nationwide network of patient service centers and coverage by most health plans to make genetic testing more accessible.
7 investors
Johnson & Johnson is a diversified healthcare company operating across 260 subsidiary companies with approximately 138,000 employees globally. The organization develops pharmaceuticals, medical devices, and healthcare solutions across therapeutic areas including cardiology, oncology, immunology, neuroscience, and orthopaedics, alongside digital health and surgical robotics technologies.
7 investors
Kernal Bio is a synthetic biology company developing selective mRNA drugs to treat serious illnesses, with a focus on cancer therapeutics and improving patient outcomes.
7 investors
Kheiron Medical Technologies developed AI-powered breast cancer diagnostic tools, including Mia™, which assisted radiologists in breast screening decision-making. The company was acquired by DeepHealth in 2024 and its technology now supports SmartMammo™, an AI solution for breast cancer diagnostic workflows.
7 investors
Level Zero Health develops electrochemical and microfluidic biosensor platforms for point-of-care and continuous diagnostic devices. The company serves healthcare providers and patients requiring faster, more accessible diagnostic solutions.
7 investors
Coroyawa is a specialized flooring material designed to reduce fracture and trauma risk for elderly users by combining stable walking comfort with impact absorption during falls. The product uses mechanical metamaterial technology to remain firm during normal walking while deforming to absorb shock upon impact, targeting hospitals and care facilities in Japan.
7 investors
Mediartx develops novel therapies for patients with fibrotic diseases.
7 investors
Mercy develops blood-based tests for early cancer detection using its patented Mercy Halo platform, which applies qPCR technology and extracellular vesicles to identify combinations of cancer-associated biomarkers. The company aims to provide low-cost, broadly accessible diagnostics that detect cancer at its earliest, most treatable stages.
7 investors
A biopharmaceutical company developing targeted oncology medicines, with a focus on treatments for patients of all ages including children with cancers such as pediatric low-grade glioma (pLGG). It uses a "search & development" strategy grounded in cancer biology to identify drug programs, and is part of Servier.
7 investors
Moderna develops mRNA-based medicines for infectious and serious diseases using its proprietary mRNA platform and design technology.
7 investors
Nalu Medical develops a miniaturized, battery-free implantable pulse generator (mIPG) and neurostimulation system that delivers electrical pulses to modulate pain signals for patients with chronic neuropathic pain. The FDA-cleared system is used for spinal cord stimulation and peripheral nerve stimulation, powered by an externally worn Therapy Disc and controlled via a smartphone app.
7 investors
Neumora is a clinical research company developing investigational medications, with a focus on conducting clinical trials to obtain regulatory approval and make treatments available to patients.
7 investors
ONL Therapeutics is a clinical-stage biopharmaceutical company developing therapies to preserve sight by preventing Fas-mediated death of retinal cells, a cause of vision loss and blindness. Its lead candidate, xelafaslatide (formerly ONL1204), is a first-in-class small peptide targeting Fas-mediated signaling across multiple eye diseases.
7 investors
Osteoboost develops an FDA-cleared bone health device to treat osteopenia in postmenopausal women. The company builds a wearable medical device grounded in clinical research to help maintain bone density and reduce fracture risk.
7 investors
Outpace Bio develops engineered protein technologies and cell therapies to treat solid tumors, focusing on protein design and T cell engineering to improve cancer treatment efficacy and safety.
7 investors
Paperspace provided cloud GPU infrastructure and a machine learning development platform, Gradient, for training and deploying AI models. It was acquired by DigitalOcean in 2023.
7 investors
Peptilogics is a clinical-stage surgical therapeutics company developing zaloganan (PLG0206), a novel anti-biofilm drug to treat and prevent medical device-related infections such as prosthetic joint infections. Its lead candidate is in a pivotal Phase 2/3 trial and holds FDA Orphan Disease, Fast Track, and QIDP designations.
7 investors
Probably Genetic operates a platform for diagnosing genetic diseases, providing comprehensive genetic data and testing to patients and healthcare providers. The company works with patient advocacy groups to connect patients with genetic conditions to diagnostic services and community support.
7 investors
QD Laser develops semiconductor laser technology, including ultrashort-pulse DFB lasers for non-thermal micromachining of materials and its Visirium retinal-projection technology that projects images directly onto the retina for people with low vision. Its products span optical communications, industrial processing, and medical/assistive devices such as the RETISSA retinal-projection viewers.
7 investors
RayzeBio develops radiopharmaceutical therapies for cancer treatment. The company is a subsidiary of Bristol Myers Squibb focused on advancing targeted cancer therapies to patients.
7 investors
RL Medical develops wireless power transfer technology for implantable medical devices through its Aurion WPT platform, along with in-house modeling and design software (BioPWR and BioPRD) built for implantable power. It serves medical device companies, providing wireless power and data transfer to enable smaller and longer-lasting implants.
7 investors
Rubedo Life Sciences develops therapeutics targeting aging by eliminating senescent cells to extend human healthspan. The company applies artificial intelligence and chemistry to drug discovery in the longevity and regenerative medicine space.
7 investors
RxSight develops the Light Adjustable Lens (LAL), an FDA-approved intraocular lens that surgeons can adjust after cataract surgery to fine-tune a patient's prescription once the eye has healed. The company's monofocal lens targets cataract surgery and vision correction, including astigmatism as low as 0.50 D.
7 investors